154 related articles for article (PubMed ID: 34734510)
1. Skin Test Results and Cross-Reactivity Patterns in IgE- and T-Cell-Mediated Allergy to Gadolinium-Based Contrast Agents.
Grueber HP; Helbling A; Joerg L
Allergy Asthma Immunol Res; 2021 Nov; 13(6):933-938. PubMed ID: 34734510
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity to gadolinium-based contrast.
Sáenz de Santa María R; Labella M; Bogas G; Doña I; Torres MJ
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):300-306. PubMed ID: 37357781
[TBL] [Abstract][Full Text] [Related]
4. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
5. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
[TBL] [Abstract][Full Text] [Related]
6. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
7. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity reactions to gadolinium-based contrast agents.
Fok JS; Smith WB
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
[TBL] [Abstract][Full Text] [Related]
9. Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
Parillo M; Mallio CA; Van der Molen AJ; Rovira À; Ramalho J; Ramalho M; Gianolio E; Karst U; Radbruch A; Stroomberg G; Clement O; Dekkers IA; Nederveen AJ; Quattrocchi CC;
Invest Radiol; 2023 Aug; 58(8):530-538. PubMed ID: 37185158
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity to Gadolinium-Based Contrast Media.
Gracia Bara MT; Gallardo-Higueras A; Moreno EM; Laffond E; Muñoz Bellido FJ; Martin C; Sobrino M; Macias E; Arriba-Méndez S; Castillo R; Davila I
Front Allergy; 2022; 3():813927. PubMed ID: 35386665
[TBL] [Abstract][Full Text] [Related]
11. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
[TBL] [Abstract][Full Text] [Related]
12. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
[TBL] [Abstract][Full Text] [Related]
13. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells.
Erdoğan MA; Apaydin M; Armagan G; Taskiran D
Acta Radiol; 2021 Feb; 62(2):206-214. PubMed ID: 32366109
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Schieda N; Blaichman JI; Costa AF; Glikstein R; Hurrell C; James M; Jabehdar Maralani P; Shabana W; Tang A; Tsampalieros A; van der Pol CB; Hiremath S
Can J Kidney Health Dis; 2018; 5():2054358118778573. PubMed ID: 29977584
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention.
Bäuerle T; Saake M; Uder M
Rofo; 2021 Sep; 193(9):1010-1018. PubMed ID: 33348385
[TBL] [Abstract][Full Text] [Related]
17. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
Boehm I; Hungerbühler M; Heverhagen JT
Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
Nakamura K; McGinley MP; Jones SE; Lowe MJ; Cohen JA; Ruggieri PM; Ontaneda D
J Neuroimaging; 2023 Jan; 33(1):85-93. PubMed ID: 36181666
[TBL] [Abstract][Full Text] [Related]
19. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
Behzadi AH; Zhao Y; Farooq Z; Prince MR
Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
[TBL] [Abstract][Full Text] [Related]
20. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
